Results
76,315 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Ellenbogen MichaelDirector |  EVLVEvolv Technologies Holdings, Inc.Option exercise · 10b5-1 plan | M | — 80.8K sh |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Ellenbogen MichaelDirector | EVLVEvolv Technologies Holdings, Inc. Option exercise · 10b5-1 plan | M | — 80.8K sh |
| Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Lin XichenCHIEF SCIENTIFIC OFFICER |  GPCRStructure Therapeutics Inc.Derivative conversion · 10b5-1 plan | C | — 3,939 sh | Aug 19, 2026 traded Aug 18, 2026 |
| 0 | Song EstherSee Remarks |  SYNASYNAPTICS IncGrant or award · 10b5-1 plan | A | — 4,711 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Lin XichenCHIEF SCIENTIFIC OFFICER | GPCRStructure Therapeutics Inc. Derivative conversion · 10b5-1 plan | C | — 11.8K sh | Aug 19, 2026 traded Aug 18, 2026 |
| 0 | Gupta VikramSee Remarks | SYNASYNAPTICS Inc Grant or award · 10b5-1 plan | A | — 34.6K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Hamady Robert RamseyChief Financial Officer |  SMRNUSCALE POWER CorpOption exercise · 10b5-1 plan | M | — 20.0K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Sullivan Christopher RyanChief Financial Officer |  AVTXAvalo Therapeutics, Inc.Option exercise · 10b5-1 plan | M | — 31.0K sh | Aug 19, 2026 traded Aug 18, 2026 |
| 0 | Sullivan Christopher RyanChief Financial Officer | AVTXAvalo Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 2,876 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Doyle MittieChief Medical Officer | AVTXAvalo Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 1,000 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Ashish AroraDirector, Chief Executive Officer, 10% Owner |  CRCTCricut, Inc.Derivative conversion · 10b5-1 plan | C | — 1.75M sh | Aug 19, 2026 traded Aug 19, 2026 |
| 0 | Ellenbogen MichaelDirector | EVLVEvolv Technologies Holdings, Inc. Option exercise · 10b5-1 plan | M | $19K 80.8K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Hamady Robert RamseyChief Financial Officer | SMRNUSCALE POWER Corp Option exercise · 10b5-1 plan | M | $0 0 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Gupta VikramSee Remarks | SYNASYNAPTICS Inc Grant or award · 10b5-1 plan | A | — 15.3K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Doyle MittieChief Medical Officer | AVTXAvalo Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $13K 1,000 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Lin XichenCHIEF SCIENTIFIC OFFICER | GPCRStructure Therapeutics Inc. Option exercise · 10b5-1 plan | M | $4,018 11.8K sh | Aug 19, 2026 traded Aug 18, 2026 |
| 0 | Starzak Alissa MichelleChief Legal Officer |  NETCloudflare, Inc.Option exercise · 10b5-1 plan | M | — 3,333 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Song EstherSee Remarks | SYNASYNAPTICS Inc Tax withholding · 10b5-1 plan | F | $107K 972 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Riley JanelChief Accounting Officer | NETCloudflare, Inc. Option exercise · 10b5-1 plan | M | $113K 1,667 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Sullivan Christopher RyanChief Financial Officer | AVTXAvalo Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 37.9K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Lin XichenCHIEF SCIENTIFIC OFFICER | GPCRStructure Therapeutics Inc. Option exercise · 10b5-1 plan | M | — 11.8K sh | Aug 19, 2026 traded Aug 18, 2026 |
| 58 | Musser ForySenior VP, Development |  VGVenture Global, Inc.Open-market sale | SELL | $6.27M 447.5K sh | Aug 18, 2026 traded Aug 14, 2026 |
| 55 | Musser ForySenior VP, Development | VGVenture Global, Inc. Open-market sale | SELL | $309K 22.0K sh | Aug 18, 2026 traded Aug 17, 2026 |
| 55 | Poletti Samuel JonasChief Strategy & M&A Officer |  AMRZAmrize LtdOpen-market purchase | BUY | $118K 2,510 sh | Aug 18, 2026 traded Aug 17, 2026 |
| 53 | PM Alpha II DAC10% Owner |  AB-LENDAB Private Lending FundOpen-market purchase | BUY | $1.33M 53.1K sh | Aug 18, 2026 traded Mar 2, 2026 |
| 49 | Chandrashekar LavanyaChief Financial Officer |  NWSNEWS CORPOpen-market sale | SELL | $510K 17.8K sh | Aug 18, 2026 traded Aug 17, 2026 |
| 49 | Allen RuthChief Human Resources Officer | NWSNEWS CORP Open-market sale | SELL | $624K 21.5K sh | Aug 18, 2026 traded Aug 17, 2026 |
| 46 | Delany JulianChief Technology Officer | NWSNEWS CORP Open-market sale | SELL | $50K 1,747 sh | Aug 18, 2026 traded Aug 17, 2026 |
| 45 | Mehta Amit AshvinSVP, Strategy & Business Ops |  REZIRESIDEO TECHNOLOGIES, INC.Open-market purchase | BUY | $226K 10.9K sh | Aug 18, 2026 traded Aug 17, 2026 |
| 44 | Kuhl HenrikDirector | EVLVEvolv Technologies Holdings, Inc. Open-market purchase | BUY | $86K 15.0K sh | Aug 18, 2026 traded Aug 14, 2026 |
| 43 |  Rick W. AllenRSpouse |  AMDADVANCED MICRO DEVICES INCPurchase | BUY | $1,001 – $15K | Aug 18, 2026 traded Jul 14, 2026 |
| 41 | Haznedar Carolann IDirector |  NVRIEnviri CorpOpen-market purchase | BUY | $100K 4,875 sh | Aug 18, 2026 traded Aug 17, 2026 |
| 40 | Hixon DylanDirector |  NRGVEnergy Vault Holdings, Inc.Open-market purchase | BUY | $107K 27.5K sh | Aug 18, 2026 traded Aug 17, 2026 |
| 40 | Sbragia JohnSVP, Engineering and Quality |  GATXGATX CORPOpen-market sale | SELL | $343K 1,900 sh | Aug 18, 2026 traded Aug 14, 2026 |
| 39 | Beatty Jonathan SMD, Head of Advisor Services |  SCHWSCHWAB CHARLES CORPOpen-market sale | SELL | $111K 1,000 sh | Aug 18, 2026 traded Aug 17, 2026 |
| 38 | Zawitz DavidChief Operating Officer |  VRCAVerrica Pharmaceuticals Inc.Open-market purchase | BUY | $30K 6,000 sh | Aug 18, 2026 traded Aug 17, 2026 |
| 38 |  Thomas H. Kean, Jr.RSelf |  AMZNAMAZON COM INCPurchase | BUY | $1,001 – $15K | Aug 18, 2026 traded Jul 8, 2026 |
| 38 | Lentell EricChief Legal & Strategy Officer |  ACHRArcher Aviation Inc.Open-market sale | SELL | $338K 52.8K sh | Aug 18, 2026 traded Aug 17, 2026 |
| 38 | Rick W. AllenRSpouse |  AVGOBroadcom Inc.Purchase | BUY | $1,001 – $15K | Aug 18, 2026 traded Jul 14, 2026 |
| 38 | Atalioti AthinaChief Financial Officer |  EHLDEuroholdings Ltd.Open-market sale | SELL | $3,000 300 sh | Aug 18, 2026 traded Aug 17, 2026 |
| 37 | O'Neill ShivGC AND CORP SEC |  ELANElanco Animal Health IncOpen-market purchase | BUY | $94K 3,998 sh | Aug 18, 2026 traded Aug 18, 2026 |